Author

Agavni Mesropian

Consorci Institut D'Investigacions Biomediques August Pi I SunyerORCID 0000-0002-0604-4755Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Josep Maria LlovetiD· 2 shared Roser PinyoliD· 2 shared Albert Gris‐OliveriD· 1 shared Alexis I. CocozakiiD· 1 shared Amaya López-PascualiD· 1 shared Ana Hernández de SandeiD· 1 shared Antonio Pineda‐LucenaiD· 1 shared Borja Castelló-UribeiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Josep Maria LlovetORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma

Elena Adán-Villaescusa, Borja Castelló-Uribe, Iker Uriarte, Eva Santamaría, Roberto Barbero, Miriam Belzunce, Amaya López-Pascual, Maria Ujue Latasa, Jasmin Elurbide, Emiliana Valbuena-Goiricelaya, Agavni Mesropian, Guillem Cano-Segarra, Ana Hernández de Sande, Lorenzo Nevi, Simone Carotti, , Maite G Fernandez-Barrena

This study shows that inhibiting G9a enhances the effectiveness of immune checkpoint inhibitors in hepatocellular carcinoma by improving tumor immunogenicity and T cell infiltration.

Cell Reports Medicine · Mar 31, 2026Peer-reviewedPharmacology & Toxicology

Molecular insights into early malignant transition of hepatocellular carcinoma

ZhengTao ZHANG, hong li, Lingli Chen, Tao Lu, Xinyi Shentu, Yuanhua Liu, Zhixuan Tang, Shuyi Ji, Zhixin Qiu, Yining Zou, Hong Wen, Jing Han, Zhengzeng Jiang, Jie Fan, Xinbo Gao, , Lijian Hui

This study profiles early hepatocellular carcinomas to reveal molecular mechanisms of malignancy transition, identifying TERT alterations, CNA burden, and immune evasion as key factors.

Cancer Cell · Mar 26, 2026Peer-reviewedCancer Biology